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HORMONAL CONTROL OF REPRODUCTIVE ACTIVITY IN THE EWE 
J. F. Wagner 
Eli Lilly and Company, Greenfield, Indiana 
Introduction 
There are many advantages which result 
from synchronizing the estrous period in a 
ewe flock. In situations where the ewes are 
not hand bred to the ram, the synchronization 
of estrus makes the application of artificial 
insemination (AI) techniques more efficient. 
Detection of estrus usually is more reliable 
in a synchronized flock. Only 3 to 4 days are 
needed to detect estrus in 90 percent of a 
synchronized flock, whereas 16 to 18 days are 
normally required. This allows the AI tech-
nician to plan the number of breedings and 
have semen available. When hormones are 
given in the feed, an opportunity is presented 
for improving the nutritional status of the 
flock during the breeding period. Synchroniza-
tion coupled with AI will increase the genetic 
uniformity of the lamb crop as well as uni-
formity of age. Attention and labor required 
at lambing could be easily scheduled and 
concentrated within a short period of time. 
Progesterone injections have been used for 
controlling estrus and ovulation in cattle, 
sheep, and swine. The development of potent 
orally active progestins is responsible for 
much of the recent interest in estrous cycle 
control. The first progestin shown to have 
significant oral activity in the ruminant was 
6-methyl-17 acetoxyprogesterone (MAP) (~, 
1, !1).~ wa~ner and Bush (11) reported that 
6-chloro- 6 -17 acetoxyprogesterone (CAP) 
when given orally was effective in inhibiting 
estrus and ovulation in the ewe. The first 
portion of this paper presents data concerning 
the effects of CAP on estrus, ovulation, and 
fe rtility in cycling ewes'-
Many breeds of sheep show a period of 
reproductive quiescence during the late winter, 
spring, and summer months. During the fall 
and early winter the ewe has a regular 
estrous cycle every 16 to 17 days. Therefore, 
during 7 months of the year many ewes are 
producing nothing more than wool and milk for 
their lambs. This period of reproductive 
inactivity is characterized by a failure of 
Graafian follicle maturation, estrus, and ovu-
lation. Consequently, any attempt to hormonally 
induce reproductive activity in the ane strous 
ewe requires an exogenous follicle stimulating 
hormone. 
The use of pregnant mare serum (PMS) as 
an inexpensive source of follicle stimulating 
activity has made possible the practical appli-
cation of physiological principles for the 
~Underscored numbers in parentheses refer to items in 
the Literature Cited, p. 
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induction of reproductive activity in the an-
estrous ewe. Many approaches have been used 
to induce reproductive activitywithPMS alone. 
Cole and Miller (4) introduced the method of 
two injections of-PMS spaced at a 16-day 
interval. Cole et gl. 0), Dutt C~), and Robinson 
(10) preceded the PMS injection with a series 
of proge ste rone injections. Gordon (2) and 
Allen and Lamming CD have attempted with 
little success to induce fertile estrus in the 
lactating ewe. Orally active progestins have 
increased the efficiency of hormone applica-
tion. Wagner and Bush (11) used an orally 
active progestin in the hormone sequence for 
the induction of estrus in the ewe. Anderson 
et al. (l,) have summarized the recent litera-
ture concerning hormonal induction of repro-
ductive activity in the anestrous ewe. 
The second portion of this paper presents 
studies which were designed to investigate the 
interaction ofthree hormones, 6-chloro- 6 6 _17 
acetoxyprogesterone (CAP, Na-estradiol (NE), 
and PMS and other variables such as post-
partum interval and lactation status affecting 
the induction of estrus and ovulation in the 
anestrous ewe. 
Experimental Methods 
The data presented were compiled during 
the past 4 years at South Dakota State Uni-
ve rsity and the Eli Lilly Agricultural Research 
facilities. The majority of the sheep used in 
these studies were black-faced and white-
faced crossbreds; the two breeds were equally 
represented in all treatment groups. All ewes 
treated ranged from 2 to 4 years of age and 
had produced lambs in the spring prior to 
treatment. 
In tables 1 through 4 data have been com-
piled from four experiments over 3 successive 
years on the effects of CAP in the cycling ewe. 
Dosages of CAP ranging from 0.25 mg. to 
75.0 mg. per ewe per day for 16 days were 
given in the feed (table 1). The CAP was 
dissolved in one liter of ethanol or propylene 
glycol and added to 15 lb. ofal£a1£agrits which 
was used as a premix containing 0.1 gm. of 
CAP per pound. Sufficient pre'lnix was added 
to a concentrate ration containing a minimum 
of 60 percent ground corn so that the daily 
dosage of CAP could be supplied by 1.0 lb. of 
finished feed. 
The ewes were fed in groups ranging from 
12 to 106 ewes. When in drylot, the 1.0 lb. of 
hormone feed was given in the morning sep-
arate from and prior to the daily maintenance 
ration. When on pasture, the ewes were placed 
in the drylot overnight and given the hormone 
feed before they were returned to pasture in 
the morning. 
Results in the CAP-fed ewe!ii were com-
pared with those obtained in ewes injected 
with 10 mg. of progesterone in 1 ml. of corn 
oil subcutaneously daily for 16 days. These 
progesterone-treated control ewes were 
handled the same as the treated ewes in all 
other respects. 
A minimum of two est rous pe riods (one 
cycle) was observed in all ewes before they 
were placed on progestin treatment. All stages 
of the estrous cycle were equally represented 
in each treatment group. The ewes were 
identified with ear tags and paint brands. 
Prior to and during treatment vasectomized 
rams were used to check each ewe for estrus. 
Two to three ewes at a time were placed with 
a single ram once per day in small pen and 
estrus was 0 b s e r v e d directly. Following 
treatment, the same procedure for observing 
estrus was employed using fertile rams three 
times a day. In an attempt to reduce the 
diffe rences in conception rates due to variation 
in ram fertility, most ewes were bred to at 
least two different rams per estrous period. 
Twice-daily heat checks were started 6 days 
after treatment and continued for 25 to 45 
days. The average interval from the end of 
treatment to the onset of estrus (AlE) was 
recorded and the standard deviation of these 
intervals w:..s used as a measure of the de-
gre~ of synchronization. 
Conception dates were verified at lambing 
using gestation periods of 146 days for the 
black .. faced and 148 days for the white-faced 
crossbreds (table 4). 
Twelve ewes (table 2) were divided into 2 
group's of 6 each, with one group receiving 
4.0.tn.g. of CAP per ewe per day for 10 days 
in tile feed and the other group receiving 4.0 
m4. cbf CAP plus 4.0 mg. ofethynylestradiol-3 
methyl ether (3ME) for 10 days. Treatment 
wail started on day 8 of the estrous cycle. The 
ewes' ~re laparotomized the last day of 
treatm~:ht (day 18 of cycle) and the size and 
number of follicles recorded. 
Ovulation data were observed in 12 other 
ewes receiving in the feed as described above 
various combinations of CAP alone and with 
3ME (table 3). The ewes were laparotomized 
8.5 days after the end of steroid treatment and 
the size and number of follicles and corpora 
lutea were recorded. 
Table s 5 through 13 include data accumu-
lated over a 2-year period on the effects of 
CAP, pregnant mare serum (PMS), and Na-
estradiol (NE) on the induction of estrus and 
ovulation in the anestrous ewe. The ewes in 
these studies were the same animals used for 
synchronization and all had lambed in the 
spring prior to treatment. 
One-half of all the ewes received 0.5 mg. 
per ewe per day of CAP for 16 days, and the 
other half received 1.0 mg. per ewe per day. 
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The ewes received the hormone in the feed in 
the manner as described above in groups 12to 
24. All ewes were in drylot during and 25 days 
following treatment. Ewes were maintained on 
an alfalfa-hay plus mineral ration or a com-
plete breeding ration. 
Ewes were checked for heat using the pro-
cedures previously described. Beginning on 
the day of PMS injection, the ewes were 
checked for heat 3 times a day for4 to 5 days. 
Twenty rams were available to breed each 
100 ewes placed on treatment at a given time. 
All ewes received 1,000 I.U. PMS 2 injected 
subcutaneously in the inguinal region. In the 
first experiment the PMS was given 12, 24, 
or 36 hours after the last CAP feeding, and a 
second PMS was given 16.5 days after the first 
PMS to ewes that did not show estrus following 
the first PMS (table 5.) Halfofthese ewes were 
lactating and half were dry. 
In the second study, 96 ewes were divided 
into four groups, one-half of the ewes re-
ceiving 0.5 mg. CAP per ewe per day and the 
other half 1.0 mg. CAP per ewe per day for 
16 days. These were further subdivided into a 
2 x 2 factorial with half of the ewes receiving 
500 pg. ofNa-estradiol injected subcutaneously 
and the other half receiving no Na-estradiol 
(table 6). All of these ewes and their lambs 
weaned at least 2 weeks prior to treatment. 
In the third study (tables 7, 8, 9, and 10) all 
ewes were lactating at the time of breeding, 
with inte rvals between spring lambing and 
spring breeding ranging from 30 to 79 days. 
The first PMS was given 36 hours after the 
last CAP feeding and the second PMS was 
given 16.5 days after the first PMS. The 
second PMS was given under three different 
conditions: (A) All ewes received 1,000 I.U. 
of PMS 36 hours after the last CAP feed, and 
ewes showing estrus were bred to fertile 
rams. Ewes not showing estrus were given a 
second 1,000 I.U. of PMS 16.5 days after the 
first PMS. (B) All ewes received one injection 
of 1,000 I.U. of PMS 36 hours after the last 
CAP feeding, and another 18 days after the 
last CAP feeding. Ewes showing estrus were 
bred to fertile rams. (C) All ewes received 
two injections of PMS as described in (B); how-
ever, vasectomized rams were used after the 
first PMS injection and fertile rams after the 
second PMS (table 12). None of the ewes 
received CAP between the first and second 
PMS injections. 
The ewes were divided into five groups 
depending upon their interval from lambing to 
breeding (tables 7, 8, 9, and 10). Ten-day 
periods were arbitrarily selected for each 
interval group. Any ewe showing an estrous 
pe riod following both the first and second P MS 
would appear twice in these tables in either 
the "ewes conceived" or "ewes open" column. 
Thirty-six ewes were selected from the 
first study for laparotomy 5 days after the 
2 Lyophilized PMS - Ferring AB, Malmo, Sweden 
first PMS. Thirteen of these ewes had shown 
estrus within 5 days following the first PMS 
and 23 had not shown estrus. Corpora lutea of 
at least 6 mm. in diameter and red in color 
were designated as ovulation sites attributable 
to the PMS injection. ' 
In the first experiment 84 lactating ewes 
with post-partum intervals of 30 to 69 days at 
the time of the first PMS injection were 
compared with 85 nonlactating ewes with the 
same post-partum intervals (table 13). The 
nonlactating ewes were weaned from their 
lambs at least 2 weeks prior to the initiation 
of treatment. However, some ewes had lost 
their lambs following lambing and had been 
dry for 2 to 8 weeks. 
Data from experiments I, 2, and 3 were 
compiled so as to compare results between 
years A and B (table 14). Year A represents 
experiment 2 and year B experiments 1 and 3. 
Only estrus and conception data from the first 
PMS injection are included in this comparison. 
Results and Discussion 
Cycling Ewes. Data from four experiments 
on the incidence of estrus and synchronization 
are reviewed,over a dosage range of 0.25 mg. 
to 75.0 mg. per ewe per day of CAP (table 1). 
T he effective dos age range for estrous re-
sponse appears to be 1.0 to 6.0 mg. per ewe 
per day of CAP for a period of 16 days. The 
AlE increased as the CAP dosage increased 
from 1.0 mg. to 6.0 mg. Synchronization as 
measured by the standard deviation of the 
intervals from end of CAP treatment to estrus 
clearly indicates 1.0 mg. per ewe per day 
CAP as the optimum dosage level. Dosages of 
0.25 and 0.50 mg. per ewe per day CAP re-
sulted in a significant number of ewes showing 
estrus throughout the 16-day treatment period 
(table 1). The AlE of the positive control ewes 
receiving 10 mg. of progesterone in oil sub-
cutaneously daily for 16 days was not signifi-
cantly different from the 1.0 mg. CAP dosage 
(3.1 days vs. 3.2 days, respectively). 
The development of follicles on the ovary 
during and after CAP treatments was studied, 
and the results are shown in tables 2 and 3. 
The 4.0 mg. dosage of CAP alone did not com-
pletely inhibit follicular growth, whereas with 
the addition of 4.0 mg. per ewe per day of 
3 ME, complete inhibition of follicular develop-
ment during treatment was noted (table 2). 
Eight and one-half days after a 2.0 mg. dosage 
of CAP, 11 of 12 ewes had ovulated and no 3ME 
effect on ovulation was seen (table 3). 
Conception data for the effective dosage 
range of estrous response (1.0 _ 6.0 mg. of 
CAP) appears in table 4. At the first syn-
chronized estrus, conception rates ranged 
from 23 percent to 38 percent ofthe total ewes 
treated. The positive controls had the highest 
first service conception rate (64 percent); 
the 1.0 mg. and 2.0 mg. CAP dosages had 
30 
higher conception rates than CAP at 4 mg. 
and 6 mg. pe r ewe pe r day. Following two 
services, conception rates ranged from 77 
percent to 86 percent over all treatments. 
However, no significant differences in con_ 
ception rates after two services were ob_ 
served between treatments. 
Anestrous Ewes. The 'effects of three time 
intervals (12, 24, and 36 hours) between the 
last CAP treatment and a I,OOO-I.U. PMS 
injection (subcutaneous) are shown in table 5. 
The percentage of ewes in estrus was signifi_ 
cantly higher (70 percent vs. 43 percent -
P < 0.05) than the percentage in heat in the 
12- and 24-hour CAP-PMS t~eatments. Estrous 
responses following a second PMS injection 
16.5 days after the initial PMS were approxi_ 
mately the same for each CAP-PMS interval 
regime (range 70 percent to 75 percent). The 
average AlE was significantly shortened (P 
< 0.05) as the CAP-PMS intervals were in_ 
creased. The AlE after the second PMS was 
not influenced by the CAP-PMS intervals. 
Estrous synchronization was decreased (stand-
ard deviation increased) following the second 
PMS injection (P < 0.05) when compared to 
the initial estrous synchronization. 
The use of NE (500 pg) injected subcutane-
ously 36 hours following PMS (1,000 I.U.) in_ 
creased the percentage of ewes showing estrus 
(table 6). However, those ewes receiving the 
NE had a significantly lower conception rate 
(P < 0.05) when compared to those receiving 
only the CAP-PMS treatment. 
The interval from parturition to the CAP-
PMS induced estrus was' studied relative to its 
effects upon the. induction of estrus and con-
ception. The interval from spring lambing to 
the hormone-induced estrus following the first 
PMS ranged from 30 to 69 days (table 7). The 
post .. partum interval (PPI) had no significant 
effect upon the induction of estrus. However, 
the PPI did have a significant effect upon 
conception. It is shown in table 8 that ewes 
bred between 50-59 days post partum had the 
highest conception rate (X2 = 15.57). 
The average PPI to conception for 107 ewes 
was 47.4.:t 14.5 days. Eighty_seven of these 
ewes were allowed to breed naturally after 
lambing in the fall (October). The PPI to con-
ception in the fall was 48.5 .:t 14.9 days. It is 
apparent that similar time relationships gov-
erning the ability of the ewe to conceive while 
lactating are in effect during both the spring 
and fall months. A covariance of PPI to con-
ception was calculated between spring and fall; 
no correlation was noted (r = -.13). 
Ewes showing estrus following the second 
P MS injection had a higher conception rate 
when compared to ewes bred following the 
first PMS treatment (1st PMS 56.9 percent 
vs. 2d PMS 72.0 percent and 66.7" -percent -
P < 0.05, tables 8, 9, and 10). This higher 
conception rate following the second PMS 
could be due to two factors: (1) the average 
PPI to conception was 16.5 days longer, and 
(Z) the second PMS was given in the presence 
f a regressing corpus luteum, whereas the ~'rst PMS was given following CAP treatment. 
1 The shortest PPI at the time-of the second 
PMS injection was 4Z days, which could 
account for PPI not affecting the conception 
rate following the second PMS (tables 9 and 10) 
(X Z = 0.7 and 0.3, respectively). Considering 
PPI independently of first or second PMS 
injection it would appear that 40 to 60 days 
following spring lambing are necessary for 
optimal conception to a hormonally induced 
estrus. 
Gordon, 1963, reported that lactating ewes 
had a low conception rate following a progestin-
PMS t rea t men t, but following a second 
progestin-PMS regime, the conception rate 
was signific antly improved. Howeve r, Gordon IS 
studies as well as the ones described in this 
report do not separate the effects on conception 
of post-partum interval from the effects on 
conception of the second PMS. 
It was assumed that the second PMS was 
given in the presence of a regressing corpus 
luteum and it should be noted that 35 of 36 
ewes ovulated following a CAP-PMStreatmel1t 
(table 11). Twenty-three of these 36 ewes had 
not shown estrus following PMS; however, 
ZZ ovulated within 5 days after the PMS 
injection. 
When the second PMS was given to a group 
of ewes which conceived following the first 
PMS, no differences in conception rate could 
be shown when compared to ewes which re-
ceived a single PMS injection (Treatment A 
vs. B, table 12). Fifty percent of 46 ewes 
conceived following an initial injection of 
PMS; 62.9 percent of 27 ewes which received 
two PMS injections conceived following the 
first PMS. Of the 40 ewes not bred following 
the first PMS injection, 24 (60 percent) came 
into estrus following the second PMS injection 
and 66.6 percent of these lambed (table 12). 
Compared to the incidence of estrus following 
the first PMS, this was a reduction of 12.5 
percent. 
The effect of lactation upon the hormonal 
induction of estrus and conception in the ewe 
is shown in table 13. In this study the lactating 
ewes had a significantly higher incidence of 
estrus and rate of conception (P < 0.05) when 
compared to the nonlactating ewes. 
The ewes treated with 0.5 mg. of CAP per 
day for 16 days followed 24 hours later by 
PMS showed a significantly higher incidence 
of estrus in year A; in year B there was no 
difference between 0.5 mg. and 1.0 mg. of 
CAP (table 14). Of those ewes which showed 
heat, no difference in conception rates could be 
seen in year A; in year B the 1.0 mg. CAP 
dose was significantly higher (P < 0.05). 
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Summary 
In the fall months, ewes in which at least 
two estrous periods were observed were fed 
various levels of CAP for a 16-day period. 
Upon withdrawal of CAP from the feed, the 
incidence of estrus, incidence and rate of 
ovulation, and percentage of conception were 
recorded. Dosages of CAP ranging from 0.25 
mg. to 75.0 mg. per ewe per day were admin-
istered in the feed. The minimal dosage of 
CAP for complete inhibition of estrus and 
ovulation was 1.0 mg. per ewe per day. Eighty 
percent of the ewes treated with 1.0 mg. CAP 
came into a synchronized estrus following 
treatment. Ninety-three percent ofthe positive 
controls (10 mg. per ewe per day of proges-
terone injected daily for 16 days) showed 
estrus following treatment. The conception 
rates of the first two services following treat-
ment in the 1.0 mg. dosage group and the 
positive control group were 86 and 84 percent, 
respectively. The conception rate at the first 
service subsequent to treatment was higher in 
the positive controls. 
Lactating and anestrous ewes were treated 
with CAP for 16 days followed by an injection 
of 1,000 I.U. of PMS. Na-estradiol was added 
as supplemental estrogen to some ewes 36 
hours after PMS. In addition, a second PMS 
injection was used in various studies 16.5 days 
after the first PMS treatment. The optimum 
interval from the last CAP treatment to the 
first PMS injection was 36 hours. The use of 
500 pg. of NE to supplement the estrogen 
from the P MS -induced follicle reduced the 
conception rate significantly. The interval 
between parturition and breeding had a sig-
nificant effect on conception, but no effect 
upon the induction of estrus. Forty to 60 days 
after lambing were necessary for an optimal 
conception rate. Ovulation occurred following 
CAP-PMS treatment in 35 of 36ewes. Twenty-
three of these ewes had not shown estrus fol-
lowing PMS, but 22 had ovulated. A second 
PMS 16.5 days after the first PMS was there-
fore employed to induce another estrus in the 
presence of a regressing corpus luteum re-
sulting from the first PMS treatment. In those 
ewes showing estrus the conception rate was 
significantly higher after the second PMS when 
compared to the conception rate following the 
first PMS. The second PMS did not affect 
conception rate following the first PMS. Inone 
_ study lactating ewes appeared to have a higher 
percentage of ewes in estrus and a higher 
lambing percentage when compared to non-
lactating ewes. The optimal dosage of CAP in 
the hormone sequence ranged between 0.5 mg. 
and 1.0 mg. per ewe per day. 
( 1 ) 
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Table l.--CAP levels for the synchronization of estrus in the ewe, 
summary of 4 experiments 
Ewes b Ewes c 
in estrus in estrus 
AlEd Treatmenta No. during following 
CAP of treat. treat. 
mgjewejday ewes % % Days** ± st. dev.** 
0.25 20 80 0 
0.50 72 8 25 4.2 1.5 
1.0 279 0 80 3.2 0.8 
2.0 22 0 73 4.6 0.9 
4.0 22 0 78 5.9 2.6 
6.0 22 0 95 7.4 3.1 
25.0 9 0 11 12.0 
50.0 9 0 0 
75.0 9 0 0 
Progesterone e 45 0 93 3.1 0.5 
a CAP given in 1.0 lb. of concentrate daily for 16 days. 
b Ewes showing estrus within 24 hours after the initiation of treatment 
are not included. 
c This percentage includes all ewes in estrus between 2.5 and 9.0 days 
after the withdrawal of CAP except for the 25.0 mg. CAP treatment. 
dAlE = Average interval from end of CAP treatment to onset of estrus. 
e Ten mg. of progesterone in oil per ewe were injected subcutaneously 
daily for 16 days. 
** With the exception of the 0.5 mg. CAP dose, these values increase 
significantly (P < 0.01) as the CAP dose increases, (CAP dose vs. 
interval - r = 0.9). 
Table 2.--The effect of CAP and 3ME upon follicular development 
in the ewe 
Day of Day of 
Treatment No. cycle cycle Follicles 
CAP 3ME of treat. treata Av. Size b 
mgjday mgjday ewes started ended no. mm. 
4 0 6 8 18 3.2 5.8 
4 4 6 8 18 0 0 
a Ewes laparotomized on last day of treatment; follicles and corpora 
lutea measured. 
b No follicles 2 mm. or less were recorded. 
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Table 3. __ Ovulation in the cycling ewe following steroid treatment 
Ovarian resEonse following treatmenta 
Average Average 
TreatInent No. follicle CL 
CAP 3ME of size size No. of ewes 
mg/day mg/day ewes mm. mm. ovulated 
2 0 4 8 8 4 
2 1 4 7 9 3 
2 4 4 6 7 4 
a Laparotomy performed 8.5 days after end of treatment. 
Table 4. - - The incidence of estrus and the percentage of ewes conceiving 
subsequent to CAP treatment 
First Second Ewes 
No. estrus estrus lambed to 
Treatmenta of follow. Ewes follow. Ewes first + second 
CAP 
mg/ ewe/ day 
1 
2 
4 
ewes 
treated 
6 c 
Progesterone 
279 
22 
22 
22 
45 
treat. 
%b 
80 
73 
77 
95 
93 
lambed 
%b 
38* 
36 
27 
23 
64* 
treat. 
%b 
59 
59 
64 
73 
36 
lambed 
%b 
48 
45 
54 
54 
20 
: CAP fed in 1.0 lb. of concentrate per ewe for 16 days. 
Percentages based on total number of ewes treated. 
estrus 
%b 
86 
82 
82 
77 
84 
c Ten mg. of progesterone in oil per ewe injected subcutaneously daily 
for 16 days. 
* Significant (P < 0.05) from 4 and 6 mg. CAP treatment groups. 
Table 5.--Effect of CAP-PMS interval on induction of estrus 
Int. between 
end of CAP Ewes in estrus 
treat.a and No. First+Secondb First + Secondb AlEC 
PMS inject. of servo servo servo First PMS Second PMS 
hr. ewes 0/0 0/0 0/0 Days !S.D. Days :rS.D. 
12 59 47 71 88 2.2 0.2 2.7 1.0 
24 60 38 75 85 1.8 0.2 2.8 1.0 
36 60 70 70 92 1.6 0.3 2.8 0.7 
a All ewes received 0.5 or1.0mg/ewe/dayofCAP administered in 1.0 lb. 
of ground corn for 16 days. 
b All ewes not showing estrus following the first PMS injectior.. (1,000 I.U.) 
received a second PMS injection 16.5 days after the initial PMS. 
c AlE = Average interval from PMS to the onset of estrus. 
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Table 6 ••• The effect of CAP.PMS with and withoutNa.estradiol 
upon estrus and conception 
Ewes lambed 
T reatmenta No. Ewes in Of total Of ewes 
CAP Na.estradiol of estrus treated in estrus 
mg/ewe/day IIg/ewe ewes 0/0 0/0 0/0 
0.5 24 83 42 50 
1.0 24 33 17 50 
Total 48 58 30 50 
0,5 500 24 92 17 18 
1.0 500 24 100 21 21 
Total 500 48 96 19 20 
a All ewes received CAP for 16 days followed by 1,000 I,U. of PMS 24 
hours after the last CAP feeding. 
Table 7 .... Relationship of post.partum interval to the hormonal induction 
of estrus in the lactating ewes 
Total ewes 
PPla Ewes in estrus Ewes not in estrus Total ewes in estrus 
days No. No. No. % 
30.39 67 33 100 67.0 
40.49 15 1 16 93.8 
50.59 42 18 60 70.0 
60.69 15 5 20 75.0 
Total 139 57 196 71.0 
X2 = 5.1 
a PPI = Post.partum interval to the hormone.induced estrus. Ewes 
received CAP for 16 days followed by two 1,000.I.U. injections of PMS 
36 hours and 18 days after the last CAP feeding. 
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Table 8. _ -Relationship of conception and post-partum intervals of 
lactating ewe s to the first P MS injection 
Total ewes 
PPIa Ewes conceiving Ewes open Total ewes conceiving 
days No. No. No. % 
30-39 17 27 44 38.6 
40-49 8 5 13 61.5 
50-59 27 6 33 81.8 
60-69 6 6 12 50.0 
Total 58 44 102 56.9 
x 2 = 15.6 
a PPI = Post-partum interval to the hormone-induced estrus. The ewes 
received CAP for 16 days followed by 1,000-I.U. injections of PMS 36 
hours after the last CAP feeding. 
Table 9.--Relationship of conception and post-partum interval 
of lactating ewes receiving a second PMS injectiona 
PPIb 
Total ewes 
Ewes conceiving Ewes open Total ewes conceiving 
days No. No. No. % 
50-59 12 6 18 66.6 
60-69 5 2 7 71.4 
70-79 9 2 11 81.8 
Total 26 10 36 72.0 
X 2 = 0.7 
a The second PMS was given under two experimental conditions: 
(1) to ewes which did not show estrus following the first PMS 
(2) to ewes which did show estrus following the first PMS and were 
bred to fertile. rams after both first and second PMS. 
b PPI = Post-partum interval = interval from lambing to estrus following 
second PMS injection. 
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Table 10.--Relationship of conception and post-partum intervalof 
lactating ewes receiving a second PMS injectiona 
PPIb 
Total ewes 
Ewes conceiving Ewes open Total ewes conceiving 
days No. No. No. 0/0 
40-49 3 2 5 60.0 
50-59 5 2 7 71.4 
60-69 3 1 4 75.0 
70-79 5 3 8 62.5 
Total 16 8 24 66.7 
2 X = 0.3 
a None of the ewes were bred following the first PMS; therefore, all 
ewes were nonpregnant at the time of the second PMS injection. 
b PPI = Post-partum interval;: interval from lambing to estrus following 
second PMS injection. 
Table ll.--The effect of CAP-PMS treatment upon ovulation in 
anestrous ewesa 
Total Ewes Total Average 
Ewes· ewes ovulated ovulations No. of 
showing: No. No. No. ovulations· Range 
Estrusb 13 13 52 4.0 1-6 
No estrusb 23 22 58 2.6 0-5 
Total 36 35 110 3.1 0-6 
a All ewes received 0.5 or 1.0 mg. of CAP per day for 16 days followed 
by 1,000 I.U. of PMS 12, 24, or 36 hours later. 
b Where possible, ewes were selected for laparotomy 5 days after the 
first PMS on the basis of one ewe showing estrus and two not showing 
estrus. 
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Table 12.--The effect of the second PMS upon conception following 
the first PMS injection 
1st PMS 2d PMS 
No. Ewes in Ewes in 
of heat Ewes lambed heat Ewes lambed 
T re atmenta ewes No. No. % No. No. 0/0 
Ab 77 46 23 50.0 19 13 67.4 
BC 39 27 17 62.9 16 13 81.2 
Cd 40 29 24 16 66.6 
a All ewes received either 0.5 or 1.0 mg. of CAP jewejday in 1.0 lb. of 
feed for 16 days. 
b A = all ewes received 1,000 I.U. of PMS 36 hours after the last CAP 
feed and those ewes showing estrus were bred to fertile rams. Those 
ewes not showing estrus were given 1,000 I.U. of PMS 16.5 days after 
the first PMS. 
c B = all ewes received two injections of 1,000 I.U. of PMS 36 hours 
and 18 days after the last CAP feed. Ewes showing heat were bred to 
fe rtile rams. 
d C = all ewes received two injections of 1,000 I.U. of PMS as de-
scribed in (B); however, vasectomized rams were used after the first 
PMS injection and fertile rams after the second PMS. 
Table 13. - - The effect of lactation upon the hormonalinduction of 
estrus and conception in the anestrous ewe a 
Lactation 
status 
Lactating 
N onlact ating 
Total ewes 
No. 
84 
85 
Ewes in heat 
No. % 
55 
39 
65.4 
45.9 
Ewes lambed 
No. %b 
31 
16 
56.3 
41.0 
a All ewes received 0.5 or 1.0 mg. CAP jewejday for 16 days followed 
by PMS at 12, 24, or 36 hours following the last CAP feed. Second PMS 
data not included. 
b The percentage is based on the number of ewes in heat. 
Table 14.--The effect of year and level of CAP on the hormonal 
induction of estrus and conception in the anestrous ewe 
Treatmenta 
CAP Total ewes Ewes in heat Ewes conceived 
Year mgjewejday No. No. o/n No. %b 
A 0.5 24 20 83 10 50 
1.0 24 8 33 4 50 
B 0.5 137 82 60 36 44 
1.0 148 85 57 51 60 
a All ewes received CAP in 1.0 lb. of feed for 16 days followed by 
1,000 I.U. of PMS per ewe 12, 24, or 36 hours after the last CAP feed. 
Data of second PMS injection were not included. 
b The percentage is based on the number of ewes in heat. 
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DISCUSSION 
DR. DZIUK: I would like to ask Jack Wagner 
what breed of ewes he is talking about that are 
anestrous. 
DR. WAGNER: Basically, two types, black-
face western with a high percentage of Suffolk 
and columbia and whiteface westerns with 
about 50 percent Rambouillet. These were 
usually equally distributed between all expe ri-
mental groups. Breeds were not mentioned 
because we saw no distinction between these 
two types of breeds, one which tends to show 
more cycling in the spring. 
II).credibly, we saw very few heat periods in 
the I whiteface Rambouillet ewes prior to or 
following treatment. Nearly all heat periods 
were inhibited. We checked differences prior 
to and following treatment. 
DR. TERRILL: What was the explanation for 
the better response in the lactating versus 
nonlactating ewes? 
DR. -VAGNER: I have none. This particular 
respon~ l did puzzle us. We were expecting and 
hoping for equivalent responses indicating it 
was not lactation but some variable associated 
with time post-partum. 
We have other experiments showing a lower 
response in the la,ctating ewe. They cannot be 
compared directly with these experiments 
since they were run in different years and 
different variables were examined, but the 
lactating ewes did not respond as well as the 
nonlactating ewes. 
DR. CASIDA: I was wondering what arrange-
ments you made to have the two groups com-
parable with the exception of lactation. How 
did you select? How did you get your non_ 
lactating ewes? 
DR. WAGNER: Post-partum interval was 
equally distributed in all experimental groups. 
DR. CASIDA: But did you deliberately take 
the lambs away from the nonlactating ewes at 
birth so the sample used was quite com-
parable? 
DR. WAGNER: The lambs were not removed 
from the ewes at birth, but as I recall, at 3 or 
4 weeks of age. The ewes were placed on 
treatment 2 weeks later. Post-partum inter-
vals were equally distributed between groups, 
and half of the ewes had their lambs weaned 
from them so the post-parturn interval would 
be the same in both groups, the only difference 
being weaning. These were the only variables 
that we could control in the experiment. Of 
course, breeds were equally distributed and 
weights and sizes of ewes were 'equally dis-
tributed as much -as possible between the 
lactating and nonlactating groups. 
DR. CASIDA: Have you any data on birth 
weights from the ewes that were bred during 
the otherwise anestrous season for comparison 
with the normal birth weights of spring-horn 
lambs from the same ewes? 
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DR. WAGNER: We have the data but we have 
not looked at them. We probably have around 
200 comparisons. 
I would say, just from casual observation of 
procedures in the spring and the fall, that the 
lambing weights were pretty close together. 
lim afraid we feed our ewes too well to show a 
real difference. Our lambs are too big really; we 
have a lot of dystokia. We have triplets that 
weigh 9 to 10 pounds each and quadruplets that 
weigh 8 pounds each. In some of these experi-
ments we were running 30 to 40 sets of triplets, 
and 15 to 20 sets of quadruplets. We were having 
problems saving all the lambs but not neces-
sarily because they were small. 
DR. TERRILL: Are the ewes in drylot or on 
pasture during the summer? 
DR. WAGNER: This was another variable 
which we investigated; drylot hay vs. drylot 
grain vs. pasture. There really wasnlt much 
pasture because of a dry fall. Actually, we had 
two locations with pasture and drylot and then 
three types offeed: grain (high concentrate, high 
energy), hay, and pasture. We were expecting to 
see differences and saw none. About 40 ewes 
were induced in each of these variables. 
DR. NALBANDOV: I would like to ask a ques-
tion for clarification on one point from you, Dr. 
Hansel. You mentioned that one of the obstacles 
to synchronizing heat in swine will be. or is, 
cystic ovaries. 
I have never worked with synchronization of 
heat in swine but I have done considerable work 
on feeding progestogens to pigs in corpus,luteum 
studies. We must have gone through,I suppose, 
nearly 500 pigs, but with proper dos es we never 
get cysts in the ovaries which we have examined 
at all stages in pregnant and nonpregnant swine. 
What is the explanation for the discrepancy? 
DR. HANSEL: The answer or the key to the 
answer, of course, is in the phrase "the proper 
dose." 
In making that statement I was, to some 
extent, quoting Nellorls two papers on this 
subject where he found a very high incidence of 
cystic ovaries. 
If you will look on the handout (the first 
experiment on table 4) where swine were fed 
a progestin (a Searle compound), you will see 
that half or more of them fed at a level of 
0.3 mg. per lb. had cystic follicles. A lesser 
incidence was noted at 0.5 mg. per lb. 
Dose, of course, is a key, and I think, if 
you get the right dose for every pig, your 
statement is,probably true. 
I must a,~ you, then, Andy, what is your 
dose level,' and how do you control it so 
accurately? Certainly as one looks through the 
literature a pretty high incidence of cysts is 
reported. 
DR. NALBANDOV: I will need some help on 
this. I do not remember the dosages, but I 
think on 25 mg. of injected progesterone we 
invariably get cysts, and when we inject 50 mg. 
we never get cysts. On feeding the progestogen, 
what is the dose we have used? Dr. Dziuk? 
DR. DZIUK: 400 or 500 mg. of MAP in the 
feed. 
DR. NALBANDOV: 400 or 500 mg. results in 
no cysts. 
DR. ZIMBELMAN: One thought has occurred 
to me which might be important here. I don't 
know, but I think that at low levels (Dr. First 
really could speak to this more accurately) 
the cysts occur during treatment. You are 
apparently using levels high enough to block 
this effect. If you have slightly higher levels 
than these which allow cysts to occur during 
treatment, then you may get them shortly after 
withdrawal. If you are feeding higher levels 
so that you have a longer period after with-
drawal until the cysts occur, then you would 
have a longer period of time in which you found 
no cysts, and therefore could say cysts do not 
occur. Perhaps if you waited a longer period 
of time they might occur. Is this apossibility? 
DR. NALBANDOV: No, I think we have 
covered that ·in that we have used several 
intervals. The various feeding experiments for 
corpus luteum suppression have lasted as long 
as 3 weeks. 
DR. ZIMBELMAN: Yes, but how about the 
withdrawal periods during which you followed 
the animals? 
DR. NALBANDOV: This we do not have, but 
my guess is that there would be no cysts even 
after withdrawal if you use a high enough dose. 
DR. HANSEL: There is a tendency, though, 
where you give higher doses, to have fewer 
cysts. Everyone seems to get this result. At 
a lower dose, perhaps a threshold dose, we 
seem to get more cysts. 
My pet explanation for this is that it results 
from a "leakage" of LH from the pituitary, 
and that at these threshold levels there is 
some LH secretion occurring. We think LH is 
luteotropic, at least in the cow. 
DR. MELAMPY: Dr. Hansel, what do you 
think about climatic o.r seasonal effects? We 
seem to observe more cystic ovaries occurring 
in our untreated animals, the nonexperimental 
gilts, in the winter months than we do at other 
seasons. We also find cystic ovaries occurring 
naturally and normally. In fact we also find 
cystic ovaries in our so-called normal preg-
nancies. 
I think we have to be careful; maybe some 
of this is just a normal situation. 
Also, what do you think of the relation of 
thyroid function to the occurrence of cystic 
ovaries following your progestin treatment in 
terms ofthe results of Leathem's experiments? 
DR. HANSEL: On the first one, is there a 
seasonal difference? I really have no informa-
tion. 
Does someone have some real data on the 
incidence of cysts in untreated animals? 
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DR. NALBANDOV: There are some English 
data. 
DR. HANSEL: Can you tell us the results? 
DR. NALBANDOV: No, except that there is a 
very distinct difference between, roughly 
speaking, the winter months and the summer 
and spring months. A highly significant dif_ 
ference. 
DR. HANSEL: Doesn't Lamond have some 
data showing some differences in progesterone 
content of corpora lutea in different seasons of 
the year? 
DR. DONALDSON: The gentleman happens 
to be here. Perhaps he will answer your 
question. 
DR. LAMOND: Thank you, I thought I would 
probably get out of this one, but I didn't. 
I have done two major experiments in sheep 
and cattle, in which we have examined the 
effects of progesterone on the interval from 
the final injection to the onset of estrus. And 
we find significant seasonal differences in 
both cattle and sheep. 
This will be given in more detail, I think, in 
an article in the Journal of Reproduction and 
Fertility. 
DR. HANSEL: In which direction were the 
differences in terms of the seasons in 
Australia? 
DR. LAMOND. Progesterone has a greater 
suppressive action in the sheep during the 
period from June through to August, which is 
early winter, I take it, and that is about what 
you would expect. In the cow, it is the same 
actual months of the year, or in our March to 
June which is near spring. Let me think about 
this. 
The way I presented the data was in a graph 
in which I plotted a kind of a score, a repro-
duction score. It actually indicates that the 
greatest suppressive action of progesterone 
in the cow is in our autumn and early winter, 
and in the sheep is in our early winter and 
midwinter period. This is quite a clearcut 
effect of progesterone, both on the actual 
suppression of ovarian cycles and on the in-
terval to onset of estrus, and also, I suspect, 
on cystic ovaries. 
DR. HANSEL: Very good. Now, there was 
more to that question, Bob? 
DR. MELAMPY: Well, I wonder whether you 
think we are dealing with any thyroid problems, 
such as in Leathem's experiments on the rat 
where he has been able to modify the cystic 
ovary situation in terms of thyroid function. 
Do you think that could be involved here in the 
seasonal problem dealing with pigs? 
DR. HANSEL: It could be. There are some 
data coming from Dr. Louw in South Africa in 
which he says that there is a reciprocal 
relationship between TSHsecretion and gona-
. dotrophin sec retion. 
When he feeds lambs stilbestrol he inhibits 
gonadotrophin content of the pituitaries and 
increases the TSH content and the thyroid 
tivity in the ewes, as measured by increased 
ac ithelial cell height, greater oxygen consump-
:.p n and higher blood glucose levels. More 10c~ntly he has claimed that the reverse is 
:eue There may well be an interrelationship 
b:tw'een TSH and gonadotrophin secretion. 
Would someone else in the audience like to 
comment to that point? Dr. Louw's data will 
be presented at the conference at Trento, 
Italy, in September, I un~erstand. • 
DR. SPIES: I would hke to ask one of the' 
three speakers, if I am not infringing upon 
Dr. Casida's and Dr. Dziuk's information to 
be 'presented this afternoon, as to whether one 
of you would care to speculate on the reason 
for the rebound effect when you compare or 
combine first and second services in both the 
sheep and the cow. Is this low effect at first 
service due to an effect on the ovary, systemic 
hormone imbalance, or what? 
DR. HANSEL: Bob, you haven't said much 
for awhile. 
DR. ZIMBELMAN: Your question, basically, 
is why is the conception rate reduced some-
times at the synchronized estrus? I don't know. 
DR. SPIES: Why do you get the rebounding 
effect at second service? 
DR. ZIMBELMAN: And why is there a tend-
ency for perhaps even an increase in con-
ception rate at second service? I don't have 
any real data. I sO.rt of subscribe, I guess, to 
the theory t1'!lrt-/perhaps there might be a 
lingering o!some progestational effects in the 
uterus, ~1: I don't know on what basis I tend 
to view this. Whether it is an effect on the 
ovary, thinking perhaps of altered follicle 
development or ovum maturation. I don't really 
know, Harold. I have really no basis for 
speculating. 
DR. MELAMPY: I would like to ask, what 
do you mean by lingering progestationalactiv-
ity in the uterus? 
DR. ZIMBELMAN: I'll withdraw that re-
mark. Undoubtedly these compounds do have 
-progestational effects. 
One point I wanted to make in my own 
presentation is that the treated animal, as far 
as I can see, is not only under a high level of 
progestational influence but is also, in a 
sense, hyperestrogenic. I can conceive of the 
uterus as receiving a stimulation with both 
progestational and estrogenic response and 
usually, . when one tests the response of the 
uterus to a progestogen, he finds it has in-
creased with the high levels of estrogens or 
with added estrogens. Perhaps the pituitary or 
hypothalamus, or the mechanism which then 
allows the animal to ovulate, recovers more 
quickly than the uterus from this stimulation. 
Perhaps some people have studied these 
uteri histologically and would care to comment. 
I couldn't comment even if I saw the slides 
because I don't know much about this area, 
but this was the thing I was considering. And 
I would repeat that this is just a concept on 
which no data has been developed. 
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DR. HANSEL: I will go a little way out on a 
limb there, Bob. Recently, we have been 
studying the histology of uteri from heifers --
control, MAP-t rea ted heifers, and CAP-
treated--at 3 days and 10 days after breeding. 
In other words, at about 6 days after the last 
feeding and about 13 days afte r the last 
feeding. 
It does appear that there is some endome-
trial hyperplasia at three days after breeding. 
The uterus appears a little more hyperplastic 
in the treated animals which is, I suppose, a 
linger.ing progestational effect. Numbers are 
still small on this experiment and I don't want 
to go too far out on a limb. 
DR. MARION: Bill, are you implying that 
this influence is not present at 10 days? 
DR. HANSEL: Yes, insofar as the limited 
data allow. 
DR. MARION: I would say, from the his-
tological information we have on the influences 
of these compounds ort the uterine epithelium 
as well as the glandular epithelium, that this 
influence is definitely not a progestational one 
alone. I would be inclined to agree somewhat 
with the comments Bob made, to the effect 
that there is ave ry definite interaction between 
progestational influences and prob-
able estrogenic functions. The cells typically 
show estrogen stimulation when compared with 
both normal tissues from cows during the 
estrous period and also with tissue from 
ovariectomized cows under replacement ther-
apy regimes of either estradiol or ECP. The 
tissue is a little more representative of an 
estrogen stimulatipn. Whether or not this 
estrogen is produc!'ed by what we would con-
sider to be normal follicles is a bit difficult 
to say. 
I might make a further comment concerning 
the statement that Harold brought up. I think 
he has recently seen some slides presented by 
one of our students which would give part of 
the answer to his question. There is a very 
definite influence of these compounds on the 
numbers of normal-appearing follicles in the 
ovary, regardless of the treatment. I suspect 
we have a few thousand slides to verify this. 
The number of follicles that are of ovulatory 
size that would probably ovulate and be con-
sidered normal follicles is very definitely 
reduced during and shortly after progestational 
influences. The extent of histological changes 
vary with the compound used. Here we are 
referring to the differences we find with MGA, 
for example, where a greater degree of 
luteinization occurs as compared to the MAP 
compound. However, the number of follicles 
that would be considered normal, either with 
normal granulosa cells or with a normal 
appearing nonstimulated theca interna layer, 
is very definitely influenced by these com-
pounds. Perhaps what happens is that, even 
though ovulation does occur, the conception 
rate is considerably lower because of' the 
abnormal number of follicles. By the second 
synchronized estrus this has been eliminated, 
or at least part of the influence has been 
eliminated. However, if the influence is not 
only on ovulatory-sized follicles but also on 
secondary follicles, follicles that have yet to 
even produce antra, a considerable reduction 
in number may occur. . 
DR. HANSEL: Very good, Gerry. Did you 
use fairly large doses? 
DR. MARION: Yes. 
DR. HANSEL: What were your dose sizes? 
DR. MARION: Originally we used 200 mg. 
of MAP in most of our work. However, the 
MGA~ studies have varied from 0.4 mg. a day 
to 1 mg.; 0.4, 0.6, and 1 mg. per cow per day 
treatments. 
DR. HANSEL: Thank you. Bob, do you want 
to make a comment? 
DR. ZIMBELMAN: One point concerns me a 
little when we start making comparisons of 
compounds or effects like this and this is one 
that I tried to make in my paper. We have 
variations in the conception rate as I indicated 
earlier--of 25 percent in one particular trial 
to 75 percent in another. I think it is obvious 
that when 75 percent of the animals conceive, 
there couldn't have been many differences 
from the usual situation. In the case where 25 
percent conceived then there are some possi-
bilities, whether it is in the uterus or the 
luteotrophic circuit. I think that we must be 
very careful when we are talking about using 
different compounds to limit ourselves to 
situations where we have compared them 
simultaneously; otherwise the comparisons are 
completely invalid. Undoubtedly the conclu-
sions he might draw after a MAP trial in 
which he has gotten a 75 percent rate would 
be different than when he used MAP and got 
a 25 percent conception as we did in some 
instances. 
I would like to ask if this sort of control 
was present in your studies and, if not, if 
you would perhaps care to qualify the results 
to this extent? 
I think the thing we should really attempt to 
do in the future is to be a lot more specific 
on the kind of control we have here before we 
make some of these comparisons. They can be 
rather upsetting if they aren't made correctly. 
I do feel as if we are perhaps infringing on 
the next section of this program. I hope we 
aren't taking in too much of Dr. Casida's 
territory. 
DR. HANSEL: Dr. Casida has a comment at 
the moment. 
DR. CASII?A: I am interested in Dr. Zim-
belman's data on the evidenc-e of estrogen 
production while MAP was being fed. I am lost 
though as to the implication ofit. Is this simply 
a function of dose so there is not complete 
suppression of follicular development, or do 
~MGA is melengestrol acetate. The Upjohn Co., Kala-
mazoo, Mich. 
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you mean to imply that there may be some 
stimulation of follicular development by MAP. 
Just what is behind this? 
DR. HANSEL: A very good question. 
DR. ZIMBELMAN: I'm sure the answer 
won't be nearly as good. 
The question also relates to one of Dr. 
Donaldson's that I have here and have been 
pondering. If you recall the first slides, we 
showed the corpus luteum regression and then 
later illustrated increased follicular develop_ 
ment. Ths was essentially my concept of the 
development that occurs. I don't anticipate 
saying that MAP stimulates gonadotrophin 
release but rathe r that in preventing these 
follicles from ovulating it allows them to 
develop further. I had intended to comment on 
this and I think my impression is that there 
is perhaps very little influence on FSH re_ 
lease by these compounds, but they allow 
greater follicular development to occur. In 
terms of LH, I favor a concept that perhaps I 
am somewhat enchanted with, in which we have 
two centers for LH release, one for chronic 
LH release which perhaps is not being inhibited 
by the MAP and another for cyclic LH release 
causing ovulation. Therefore, we get the LH in 
low levels and FSH interacting to cause larger 
follicles and perhaps estrogen production. The 
oral progestogens perhaps block the cyclic 
release of LH which normally would cause 
ovulation. In terms of estrogenicity, I think we 
have only the gross observations, such as 
increased a<:tivity of the animals, increased 
mucus, uterine tone, vulvar swelling, and things 
of that nature when the animals are being 
inhibited. Estrogenicity is confirmed by the 
cervical mucus smear ratings, which do in-
crease. I am assuming that this is due to an 
increased estrogen activity. 
DR. CASIDA: Do you have any evidence, of a 
negative correlation between the amount of 
this and dose? 
DR. ZIMBELMAN: No, I do not have good 
data on the effect of dose on follicular fluid 
weight but in terms of the gross observations 
as determined by palpation, my impression is 
that even at 10 times the minimal dose which, 
blocks ovulation we still get a good deal of 
follicular development. I feel quite sure that 
one could show a dose relationship. I think that 
the dose required to inhibit the follicles--
this is just based on palpation obse rvations __ 
to a stage where they might not be palpable 
through a large part of the estrual cycle would 
produce an interval of 10 days or longer from 
the last feeding until the animal returns to 
estrus. I think Dr. Wagner, Dr. Hansel, and 
others have shown as you increase the dose you 
increase the interval from the last feeding to 
estrus. I think to get follic.llar suppression 
with the progestogen you produce extremely 
long delays from the las,," feeding to estrus. It 
takes this high a dose level. There probably is 
some dose relationship at the near minimal 
dosage for inhibiting ovulation. It is in this 
area that I have been talking about where the 
estrogenic influence exists, as I conceive of it, 
at least. 
DR. HULET: Dr. Foote, of Utah, who, doesn't 
appear to be here, and I have been doing some 
work in cooperation which will be reported at 
the western Section Meetings, which I would 
think is pertinent to your question, Dr. Casida. 
We have given two levels of MAP, 8 mg. 
and 16 mg., to ewes over a 20-day period. As 
I recall, on the 16th day of this period, we 
have given 1,200 I.U. of PMS to both of these 
groups. In addition, each of these groups has 
been subdivided and given estradiol-17 beta. 
I have forgotten the dosage. We found that 
there is little difference in the follicular 
development at these two different levels of 
MAP. However, ovulation rate is almost com-
pletely suppressed at the 16 mg. level but is 
only slightly suppressed at the 8 mg. level. 
And at the 16 mg. level with the estradiol the 
ovulation suppression is only very slight. It 
is comparable to the PMS given while under 
the influence of the 8 mg. MAP level. I hope 
that is of some help. 
DR. CASIDA: How do you interpret that? 
DR. HULET: I am not sure that we have the 
inte rpretation. I hope Dr. Foote will have the 
interpretation when he presents the paper. 
DR. HANSEL: I would suspect before this 
meeting is over someone is going to suggest 
that MAP or CAP, instead of inhibiting LH 
release, may actually stimulate it in achronic 
way. I don't want to be the first to do this. 
DR. DUTT: I would like to ask if anyone has 
any data onlong-termfee.dingof either MAP or 
CAP? In regard to the question of fertility, we 
have some data showing that following a single 
subcutaneous injection in ewes and we can 
consist~ntly get a cystic (we call it a cystic) 
uterus. We have drawn off as much as 2 liters 
of fluid from these uteri. We have similar 
observations in beef heifers. 
PRo HANSEL: What levels were these in-
jections? 
DR. DUTT: We used 50 mg. of MAP in ewes 
in a single injection and a single 200 mg. 
injection in heifers. 
DR. HANSEL: A condition of hydrometria. 
DR. DUTT: I wonder if anyone has really 
taken a good look at this following feeding or 
has any long-term feeding experiment been 
done? 
DR. HANSEL: Someone has a long-term 
feeding experiment. Who is it? 
DR. WAGNER: Not in ewes, but in cattle. 
The experiment was designed as a toxicology 
experiment. We wanted to treat cattle for an 
extremely long period of time. I am sure we 
are all familiar with some of the problems 
resulting from using hormones and the Federal 
Government's concern with hormone residues. 
Ten mg. of MAP was fed for 168 days. Our 
original intention was to watch the animals for 
5 or 6 days following removal and then turn 
bulls in with them and slaughter in 150-200 
43 
days and see whether or not we could finally 
get pregnancies. Only gross observations were 
made and we are not implying that the heat or 
the reproductive phenomena following removal 
were in any way, shape, or form normal. 
However, we did synchronize 75 percent of 
these animals. We had 40 animals and I think 
10 of these conceived at the first service, and 
a total of 8 percent conceived following two 
services, results somewhat similar to Dr. 
Zimbelman's 26-day data. Is the uterus ad-
versely affected following this long period? 
And if it is, for how long? Well, I would say 
not more than few days. Otherwise we would 
have not had an 86 percent conception 26 days 
following treatment. We thought we would have 
a long period of time before recovery, but did 
not. 
DR. HANSEL: It is a matter of level and 
route of administratioIl? 
FOREST JUDGE: I have a question. Where 
does this synchronized estrus occur after such 
long-term feeding? 
DR. WAGNER: As you know, we have been 
presenting our data with an average interval 
and a standard deviation from last feeding. 
These data show no difference from other 
treatments. Actually there was a difference, 
because of the fact that only one of the 40 
animals came in heat on the 3d day, and then 
about 25 came in heat on the 4th day. Thus our 
average interval and our standard deviation 
were about the same as we had been seeing, 
but actually we felt that the long treatment 
delayed them a day. 
DR. HANSEL: But essentially they were not 
greatly different from the short-term treat-
ment. 
DR. WAGNER: Not greatly different. 
DR. SORENSON: I would like to make one 
observation that we did on some MAP feeding 
for a 32-day period. First, let me give the 
reasons for doing this. From a practical 
standpoint some of our ranches would like to 
bring their cattle in as they find them in 
estrus and put them on feed, so that this 
would be some way that they would know when 
they were started. They wouldn't be just 
starting anywhere in the cycle. With this in 
mind we put some on MAP in the feedlot for 
32 days. We had some animals that we 
slaughtered at 2, 4, 8, 16, and 32 days. The 
gross observations are all I can give you now. 
The tissue is in the process of being sliced. 
The uterus went into a progestational state. 
That is, it became rather flaccid, and lacked 
tone. The ovaries had numerous small fol-
licles, throughout the 4, 8, 16, on up to the 
32-day stage. We found at 32 days that the 
uterus took on a tone that we could call almost 
an estrous tone. This was completely dif-
ferent from the l6-day uterus. At 16 days we 
still had the soft progestational type we would 
expect but at 32 days we had a firm estrous 
type, that is, an estrous feeling type of.uterus. 
As soon as we get the tissue out we'll try to 
tell you about it, but I think the results are 
interesting. 
DR. HANSEL: Very good. 
DR. GERRITS: I have a comment to make. 
We have been talking all morning about steroids 
and their effect of blocking of the estrous 
cycle and controlling of the estrous cycle. 
At Beltsville we have been doing a little 
work with a non-steroidal compound. I thought 
I might at least mention briefly some of the 
results that we have obtained. 
The compound we have been using 
is a hydrazine derivative. In the initial 
trial 34 animals were subjected to treatment. 
Twenty-two of 26 gilts fed approximately .8 to 
1.5 mg. per kg. of body weight per dayex-
pressed estrus on the 5th, 6th, or 7th day after 
withdrawal. The conception rate was 73% based 
on cleaved eggs recovered at 3 days post 
breeding or embryos recovered at more ad-
vanced stages of gestation. A paper that will 
include the details of this study will be pre-
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sented at the Fifth International Congress on 
Animal Reproduction and Art if i cia 1 Insem-
ination in Trento, Italy. I did't mean to 
interrupt the discussion on the orally active 
progestogens. However, since we are near 
the end of the section of the conference that 
deals with evaluation of methods to con-
trol the estrous cycle. I thought a men-
tion of this work would be appropriate at 
this time. 
DR. HANSEL: Well, thank you very much. 
This is an extremely interesting observation. 
I included, as did several others, inmypapers 
a plea for studies with compounds of different 
types. 
DR. SORENSON: Ray Dutt was asking about 
fluid awhile ago and this is one of the reasons 
I wanted to say what I did and then I left it 
out. We did not see any more fluid in these 
animals through these stages of 4, 8, 16, 32 
days. We did not see any change in fluid 
content of the uterus. 
